VivoSeq
Other

Chronic Periodontitis

48

Pipeline Programs

3

Active Trials

13

Companies Involved

Chronic Periodontitis is a moderately active landscape with 48 programs across 13 companies. The most active players are CD Pharma India Pvt. Ltd., Next Gen Pharma India Pvt. Ltd., EMD Serono. 12 therapies are approved with 12 more in late-stage development.

Pipeline Metrics

Competitive Density

59/100

Pipeline Velocity

0/100

Mech. Concentration

29/100

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

77

clinical trials

Completed64 · 83%
Unknown status10 · 13%
Active, not recruiting1 · 1%
Recruiting1 · 1%
Enrolling by invitation1 · 1%

Trial Activity

77 trials

Page 1 of 6

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)